drugset / Trial / NCT02758470

Muscle Fatigue and Carbonic Anhydrase Inhibitors

NCT02758470

Phase 4 Completed 13 enrolled University of British Columbia
RandomizedCrossoverDouble-blindBasic science

Summary

The objective of this research is to assess the effects of acetazolamide and methazolamide on respiratory and limb muscle fatigue development. A fatiguing protocol will be conducted for the respiratory and plantar flexor muscles and the difference in pressure/torque produced by supramaximal nerve stimulation used to assess muscle fatigue between conditions.

Timeline

Start
2016-11
Primary completion
2017-06-30
Completion
2017-06-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Acetazolamide Small molecule 250 mg Oral
Subject Methazolamide Small molecule 100 mg Oral

Indications

No indication recorded.